chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Described by (vaccinator):   Pt came in for his first covid shot.  He appeared somewhat anxious but did not cry and held still during vaccination.  He went and sat in another chair while his brother was vaccinated.  Pt then started to complain of nausea, appeared white/pale, threw up in the garbage can.  He remained pale, shaky, lethargic for about 10-15 mins.  Dr. (who was here for a covid shot) came in and examined him.  Unable to get BP due to adult BP cuff. , but once pt was laying down with feet elevated he regained some color and tremors stopped after about 30 mins.  Pt now sitting up, talking, color back to baseline.  Mother reports other anxiety attacks at school, not to this extreme.  same nausea symptoms, pale, tremor.   All seemed well so mother and patient left.
2 DAYS OF RECEIVING HEPATITIS A AND DTAP VACCINE PT STARTED WITH FEVER, DIARRHEA. MOM TOOK PT TO HOSP ON 10/28/2006 PT HAD A FEBRILE SEIZURE.
MY ARM STARTED ITCHING AND BECAME VERY SORE.  THE NEXT DAY I COULD NOT RAISE MY ARM.  TREATED WITH ICE AND TOOK BENADRYL. SEVERE RASH AROUND THE INJECTION SITE AND A HARD KNOT IN MY ARM.  THIS LASTED FOR AT LEAST A WEEK.  I WAS SICK AND VISITED AN URGENT CARE ON 07/16/2021, WITH AN ITCHY CHEST AND THROAT, AND EARACHE.  I TESTED NEGATIVE FOR COVID.  THAT NIGHT I HAD A FEVER OF 102 DEGREES.  07/17/2021  SEVERE FATIGUE, DIZZINESS,  FEVER OF 102 CONTINUED, SORE THROAT, BODY ACHES, AND CHILLS, OVERALL UNWELL. 07/18/2021 SYPTOMS CONTINUED.  WENT TO AN URGENT CARE AND THEY REFUSED TO TREAT ME AND REFERED ME TO THE ER.  I WAS DIAGNOISED WITH COVID.  THE PLACE ON MY ARM WAS MEASURED AND IT WAS ADVISED THAT I NOT RECIEVE THE 2ND DOSE.  I FOLLOWED UP WITH MY DOCTOR WHO ALSO RECOMMENDED THAT I NOT RECEIVE THE SECOND DOSE AT THIS TIME.
developed Guillain Barre Syndrome; This case was reported by a consumer via call center representative and described the occurrence of guillain barre syndrome in a 77-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, 3 months after receiving Shingrix, the patient experienced guillain barre syndrome (serious criteria GSK medically significant). On an unknown date, the outcome of the guillain barre syndrome was not recovered/not resolved.   It was unknown if the reporter considered the guillain barre syndrome to be related to Shingrix.  Additional details were provided as follows: The reporter was the wife of the patient. The age at vaccination was not reported.  The reporter declined to provide healthcare professional (HCP) information.
I developed cellulites. I noticed a red rash that was spreading, after having surgery, I knew what it looked like and I knew i had to get an antibiotic. Since that time, I get a burning sensation in the area where it was. It come and goes, its very uncomfortable.   I went to the doctor and they provided me the antibiotic, It did clear up.
This spontaneous report as received from a physician refers to a patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL 9 lot # M032650 for prophylaxis. On an unknown date the patient experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to GARDASIL 9.
I purchased 2 doses of pediatric flu vaccine for a total of $48. Twelve hours after receiving the shots (at midnight that day), I woke up with very congested lungs and I was coughing for about 30 minutes. Later, the cough subsided. Next morning I woke up fine.
Pt recv vax on 11/5/96; subsequently pt exp uncontrollable crying x2hr for 2 wk; tx=Tylenol.
7 days after receiving J & J vaccine, patient developed a severe headache at approximately 1am. He had periods of time that he couldn't recall. He experienced vertigo as well as nausea. He tried to text and it came out as a jumble of misspelled words and letters. He called me, his mother, and he was extremely hard to understand and couldn't say a complete sentence without using words that made no sense. Him being in college I was 1.5 hours away. We were able to contact a friend of his and she was able to go to his dorm room and they called the campus on call nurse line. After speaking with her she instructed them to call 911 because she thought he could possibly be having a stroke. Patient was transported by ambulance to ER.
Patient being given rabies immunoglobulin - wound irrigated without difficulty but during IM injection of balance patient got dizzy, eyes rolled back and he had a stiff/tonic seizure lasting 45 secs - after tingling hands/feet, pale, bradycardic - nauseated but no emesis.
On July 26, 2023, the patient requests information on pending covid vaccines. Patient is identified and already has two doses of bivalent vaccine with a month of separation between doses.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 30-AUG-2011, the patient was inoculated with the ZOSTAVAX vaccine by a physician as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided).  The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster. On or about 23-NOV-2016, he was treated by a physician for onset of a vesicular rash, which was diagnosed as  shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
At about hour 10 post shot, I began feeling foggy. 11 hours- chills while also feeling hot Elevated resting heart rate (100bpm) Fatigue Headache
Arm became red and swollen.  Itchy at the injection site.  This patch was about the size of a softball and stayed irritated for about 6 days.
Patient complained of red and swollen right upper arm. Given Benadryl q 6 hrs prn. 3 1/2' x 3 1/4 " area of erythema and edema. Recovery unknown, patient has 3/16/05 follow up.
Feeling hot/sweating, head ringing, body aches, chills, disorientation beginning nine hours after vaccine administration. Lasting for about nine hours.
Loss of appetite; Weight loss; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite) and WEIGHT DECREASED (Weight loss) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008E21A and 045B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (Loss of appetite) and WEIGHT DECREASED (Weight loss). At the time of the report, DECREASED APPETITE (Loss of appetite) and WEIGHT DECREASED (Weight loss) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.     Relevant concomitant medications were not reported.  Treatment medication information was not reported.  The patient had a rough month in may and was ok now.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Significant follow up : outcome of both the events Loss of appetite and weight loss were updated
I experienced what I believe to be atrial fibrillation (irregularly irregular pulse, intermittent pounding in chest, SOB with exertion, and intermittent dizziness and diaphoresis). Since I have had atrial fibrillation twice in the past with influenza illness, I did what I have been instructed to do in the past in case of recurrence.  I took Carvedilol 6.25 mg. Five hours later, after going to bed, my symptoms reduced to an irregular heartbeat (but not what I believed to be atrial fibrillation) with mild intermittent dizziness when standing. I repeated the Carvedilol dose 12 hours after the first. My heartbeat was regular 16 hours after the episode
Uncontrollable twitching around my mouth and sucking of my lips.  I insert a paper towel in my mouth in an attempt to reduce the sucking motion in my lips, but treatment for this symptom is uncharted territory.
Injection Site Swelling and pain. Chills, Muscle & Joint Aches. Fatigue.  No Nausea, no Headaches. Onset of symptoms was approximately 15 hours after vaccine injection. Resolution of most all symptoms was 10 hours after the onset of the side effect symptoms.  Completely recovered following evening.
Got the shot on Monday 4 days later on Friday had red dot rash in various sizes covering neck shoulders torso and back.  The skin felt like it was burning. As day progressed the rash spread down arms lower abdomen and buttocks and some of the dots began to have a raised pimple like head. Skin felt like a mild sunburn.  Began taking Benadryl, Pepcid, Zyrtec, and Claritin every day. 1 week later and nothing has improved.
her eczema is flaring up; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ECZEMA (non-serious), outcome "unknown", described as "her eczema is flaring up".  Additional information: Event: Patient received Pfizer Covid vaccination and MD advised to wait on her Dupixent dose until 2 weeks after 2nd dose of the vaccine. In the meantime, her eczema is flaring up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Woke up this morning with low grade fever, headache, body aches, nausea and dry heaves.  I took some ibuprofen and anti nausea med.  resolved at this time.
SUDDEN ONSET HEMATOCHEZIA 10/15/2008, ADMITTED TO HOSPITAL.  U/S NEGATIVE FOR INSUSSUSCEPTION. MECKEL'S SCAN ALSO NEGATIVE. RESOLVED SPONTANEOUSLY. 12/22/08-records received for DOS 10/15-10/16/08-DC DX:Blood in stool. Presented with 2 episodes of bloody stools on day of admission. Crying more than normal. Pain while stooling. Fussy.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. Pertinent medical history was unknown. On 15-JAN-2015 the patient was vaccinated with a dose of ZOSTAVAX (lot # K010648, expiry date: 30-OCT-2015, 0.65 ml, subcutaneous, anatomical location was unknown) that underwent an unsupported temperature excursion. Concomitant medications were unspecified by reporter. No adverse event reported. The outcome of the events was unknown. No further information provided. This case# 1501USA008296 is linked to the case# 1501USA008553 via same reporter link. Additional information has been requested.
swollen lymph node in left armpit. painful for a few days, swollen for about 10 days.
p/vax that evening devel pain in lt arm & swelling of gland under lt arm;pain is gradually decreasing but still present 5/3/99;pt checked by MD 5/1/99;no other sx;no elevated temp;
patient inadvertently received second dose of Adacel and Menactra; Initial information received on 23-Jul-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 11 years old male patient who was vaccinated with MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] lot U6219AA via intramuscular route in the left arm and -2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] lot U6202BA via intramuscular route in the right arm on 18-Jul-2019 and also received previously both the vaccines on 24-Apr-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It is an actual medication error case due to extra dose administered. It was reported that patient inadvertently received second dose of Adacel and Menactra on 18Jul2019 after had previously both the vaccines on 24Apr2019.  It was not reported whether the patient experienced any adverse event or not.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
I had COVID I was tested positive for COVID and I have had all my vaccinations (COVID-19 Vaccine); I had COVID I was tested positive for COVID and I have had all my vaccinations (COVID-19 Vaccine); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 80 year-old female patient received bnt162b2 (BNT162B2) (Lot number: Unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Arthritis" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "Verbatim: Blood pressure high" (unspecified if ongoing); "Urinary tract infection" (unspecified if ongoing); "I had a mild heart attack", start date: Nov2020 (unspecified if ongoing), notes: I had a mild heart attack in Nov2020, and I think that's about it.". The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "I had COVID I was tested positive for COVID and I have had all my vaccinations (COVID-19 Vaccine)". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive, notes: I had COVID I was tested positive for COVID (PC Filed Conservatively) and I have had all my vaccinations before that.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Fever of 104 degrees, difficulty breathing, hallucinations, chest congestion, Blood pressure extremely high, heart rate at 135 and above, weakness. Emergency room visit on 2/28/21 following the vaccine. Fever throughout the week until 3/5/21. Shortness of breath led to pulmonologist visit who administered nebulizer and prescribed inhaler, and blood pressure medicine as blood pressure remained elevated. 3 weeks after the vaccine still fighting a cough.
joint pain; asthma flare up because she did not get her medication on time; did not get her medication on time; Initial information received on 30-Nov-2022 regarding an unsolicited valid non-serious case received from a consumer.  This case involves an adult female patient who experienced joint pain, asthma flare up because she did not get her medication on time while receiving vaccine influenza vaccine and while treated with dupilumab [Dupixent] via Prefilled pen.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Asthma.  On 11-Nov-2022, the patient started taking Dupixent (dupilumab) solution pen-injector at a dosage of 300 mg every other week subcutaneously (strength: 150 mg/mL) (with an unknown batch number and expiry date) for Moderate persistent asthma.  On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (formulation, strength, dose and lot number not reported) via unknown route in unknown administration site for prophylactic immunization.  On an unknown date, the patient developed a non-serious event of joint pain (arthralgia) (unknown latency) following the first dose intake of dupilumab and (unknown latency) following the administration of influenza vaccine.  On an unknown date, the patient developed a non-serious event of asthma flare up because she did not get her medication on time (asthma) and (inappropriate schedule of product administration) (unknown latency) following the first dose intake dupilumab.  It was reported, patient reported experiencing an asthma flare up because she did not get her medication on time. Patient also reports an ER visit. Uses rescue inhaler 3 or more days per week. 2 courses of oral corticosteroids. Asthma symptoms affect quality of life alot. Missed doses. joint pain but could be from the flu vaccine. Patient states asthma attacks could be from all the stress related to trying to get medication.   Dupilumab was continued. Action taken with influenza vaccine was not applicable.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome was Unknown for all the events.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Fever, chills, headache, exhaustion.  Lasted about 3 days, missed a day of work. Was able to manage symptoms with Tylenol and rest
After a couple if hours, I had extremely sore ache ribs and spine, and then a lump in throat and stabbing pains in right side of throat.  The aches lasted several hours, but the lump in throat lasted only 1/2 hour or so, I had taken a Benadryl when I felt it.  The rib cafe and back cleared up by nighttime and the Benadryl seemed to fix my throat.  2 weeks into vaccine, I have had extreme fatigue.  Very tired.  I'm fully functional but I really want to sleep.  This is first dose so seems odd
I had a sore throat, sinus congestion, some brain fog, fatigue, cough, some loss of voice and then I've had a weird smell of cigarette smoke. I also experienced a severe headache. Symptoms currently on going.
Severe headache - nothing else 24 hrs. later - lasted the whole day. She took 1 ASA later that day and then it went away.
Patient received their second moderna vaccine shot and reported "a red, warm and painful to the touch" reaction to their injection site. They didn't receive any treatment.
Erythema, swelling, small pustules approximately 3 cm x 4 cm diameter at (R) deltoid area.
PT STATED THE SITE WAS HARD (ABOUT THE SIZE OF A TANGERINE), A LITTLE ELEVATED, AND ITCHY.
Pfizer-BioNTech COVID-19 Vaccine EUA: three days after vaccination patient presents to emergency department (ED) reporting sudden onset severe chest pain, emesis, numbness/tingling of arms, and nausea. Initial vital signs: pulse = 90 beats per minute, blood pressure 142/100 mmHg, oxygen saturation 95% on room air. Patient admitted for management of NSTEMI: differential includes myocarditis.
Dose administered from vial that had been in the refrigerator past the 30 day use by date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered from vial that had been in the refrigerator past the 30 day use by date) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered from vial that had been in the refrigerator past the 30 day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered from vial that had been in the refrigerator past the 30 day use by date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was provided by the reporter.  No treatment medication was provided.   This case was linked to MOD-2021-364236, MOD-2021-364598, MOD-2021-364962, MOD-2021-364355, MOD-2021-364754, MOD-2021-364515, MOD-2021-364819, MOD-2021-364949, MOD-2021-365131, MOD-2021-364926, MOD-2021-365177 (Patient Link).
States had flu vaccine 10/6/03 at vocational school during public clinic, states developed pain right arm and hand shortly after, few hours, seen per MD, put on antibiotics. On Celebrex at present. C/o continued pain, not feel ROM, reported to agency on 11/05/03. No redness or edema RD.
28 year old male received 2nd dose BioThrax (lot FAV043) on 3/17/00. That night, the injection site became swollen, tender, and red. The patient also began to sneeze a lot and developed respiratory blockage. Patient reported injuring his lower back as a result of the coughing and sneezing. Treatment consisted of Valium and some anti-inflammatories. Scan of back revealed rupture of L4/L5 intervertebral disks. Patient reports that he has a permanent impairment which has curtailed his activities and life style very considerably. Additionally, he has suffered from chronic recurring viral infections, protracted malaise and lassitude.
Having heartaches; Really bad headaches; It's hard to breathe at times without feeling a sharp clenching pain; It's hard to breathe at times without feeling a sharp clenching pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 17Jun2022 at 11:00 as dose 1, single (Lot number: FM7553) at the age of 26 years, in right arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Dilaudid, reaction(s): "Allergies: Dilaudid". The following information was reported: ANGINA PECTORIS (medically significant) with onset 17Jun2022, outcome "not recovered", described as "Having heartaches"; DYSPNOEA (non-serious), PAIN (non-serious) all with onset 17Jun2022, outcome "not recovered" and all described as "It's hard to breathe at times without feeling a sharp clenching pain"; HEADACHE (non-serious) with onset 17Jun2022, outcome "not recovered", described as "Really bad headaches". Therapeutic measures were not taken as a result of angina pectoris, headache, dyspnoea, pain.  No follow-up attempts are possible. No further information is expected.